BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16389562)

  • 1. Acute eosinophilic pneumonia after allogeneic hematopoietic stem cell transplantation.
    Wagner T; Dhedin N; Philippe B; Rivaud E; Vernant JP; Couderc LJ
    Ann Hematol; 2006 Mar; 85(3):202-3. PubMed ID: 16389562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Rare Complication and Diagnostic Challenges of Pulmonary Eosinophilia in Graft versus Host Disease Patients after Hematopoietic Stem Cell Transplantation.
    Tawfik P; Arndt P
    Lung; 2017 Dec; 195(6):805-811. PubMed ID: 29058073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute eosinophilic pneumonia is a non-infectious lung complication after allogeneic hematopoietic stem cell transplantation.
    Yoshimi M; Nannya Y; Watanabe T; Asai T; Ichikawa M; Yamamoto G; Kumano K; Hangaishi A; Imai Y; Takahashi T; Chiba S; Kurokawa M
    Int J Hematol; 2009 Mar; 89(2):244-248. PubMed ID: 19132457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic pulmonary syndrome as a manifestation of GVHD following hematopoietic stem cell transplantation in three patients.
    Akhtari M; Langston AA; Waller EK; Gal AA
    Bone Marrow Transplant; 2009 Jan; 43(2):155-8. PubMed ID: 18794871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of eosinophilic pneumonia which occurred after bone marrow transplantation for acute myeloid leukemia].
    Furuta K; Taki M; Murase H; Nakagawa A; Nishiyama H; Nohgawa M
    Nihon Kokyuki Gakkai Zasshi; 2011 Jan; 49(1):20-4. PubMed ID: 21384677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
    Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
    Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telemetric monitoring of pulmonary function after allogeneic hematopoietic stem cell transplantation.
    Guihot A; Becquemin MH; Couderc LJ; Randrianarivelo O; Rivaud E; Philippe B; Sutton L; Neveu H; Tanguy ML; Vernant JP; Dhédin N
    Transplantation; 2007 Mar; 83(5):554-60. PubMed ID: 17353773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent Hepatic Tuberculosis and Hepatic Graft-versus-host Disease in an Allogeneic Hematopoietic Stem Cell Transplant Recipient: A Case Report.
    Zhao Z; Leow WQ
    Transplant Proc; 2017 Sep; 49(7):1659-1662. PubMed ID: 28774674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: A Case Report.
    Szlauer-Stefańska A; Krawczyk-Kuliś M; Kamińska-Winciorek G; Bobek-Billewicz B; Giebel S
    Transplant Proc; 2020 Oct; 52(8):2551-2553. PubMed ID: 32444124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study.
    Scott MA; Gandhi MK; Jestice HK; Mahendra P; Bass G; Marcus RE
    Bone Marrow Transplant; 1998 Aug; 22(3):273-6. PubMed ID: 9720741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma.
    Reynolds C; Ratanatharathorn V; Adams P; Braun T; Silver S; Ayash L; Carson E; Eisbruch A; Dawson LA; McDonagh K; Ferrara J; Uberti J
    Bone Marrow Transplant; 2001 Apr; 27(8):801-7. PubMed ID: 11477436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between acute graft versus host disease and lung injury after allogeneic haematopoietic stem cell transplantation.
    Liu QF; Luo XD; Ning J; Xu D; Fan ZP; Sun J; Zhang Y; Xu B; Wei YQ
    Hematology; 2009 Apr; 14(2):63-72. PubMed ID: 19298716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allogeneic hematopoietic stem cell transplantation for multiple myeloma].
    Takase K; Miyamoto T
    Nihon Rinsho; 2015 Jan; 73(1):107-13. PubMed ID: 25626314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning.
    Servais S; Baron F; Beguin Y
    Transfus Apher Sci; 2011 Apr; 44(2):205-10. PubMed ID: 21345734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.
    Hong JY; Choi MK; Kim DH; Kim SJ; Kim K; Kim WS; Chung CW; Kim HO; Min YH; Jang JH
    Transplant Proc; 2010 Nov; 42(9):3723-8. PubMed ID: 21094846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short Course of Post-Transplantation Cyclophosphamide and Bortezomib for Graft-versus-Host Disease Prevention after Allogeneic Peripheral Blood Stem Cell Transplantation Is Feasible and Yields Favorable Results: A Phase I Study.
    Al-Homsi AS; Cole K; Bogema M; Duffner U; Williams S; Mageed A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1315-20. PubMed ID: 25765556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia].
    Ma X; Wu DP; Sun AN; Fu ZZ; Tang XW; Wu XJ; Liu YJ; Qiu HY; Miao M; Han Y; Jin ZM; Zhao Y; Xue SL; Wang Y; Chen SN; He GS; Zhou HX; Chang HR
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):73-6. PubMed ID: 19563014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.
    Großekatthöfer M; Güclü ED; Lawitschka A; Matthes-Martin S; Mann G; Minkov M; Peters C; Seidel MG
    Ann Hematol; 2013 Aug; 92(8):1121-8. PubMed ID: 23604429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilia predicts better overall survival after acute graft-versus-host-disease.
    Imahashi N; Miyamura K; Seto A; Watanabe K; Yanagisawa M; Nishiwaki S; Shinba M; Yasuda T; Kuwatsuka Y; Terakura S; Kodera Y
    Bone Marrow Transplant; 2010 Feb; 45(2):371-7. PubMed ID: 19525984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
    Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
    Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.